Clonal hematopoiesis mutations in plasma cfDNA RAS/BRAF genotyping of metastatic colorectal cancer

被引：0
|
作者：
Wang, B. [1 ]
Huang, F. [1 ]
Shen, M. [1 ]
Wu, S. [1 ]
Wang, H. [1 ]
Jiang, H. [1 ]
Yu, Y. [2 ]
Yu, Q. [1 ]
Yang, Y. [1 ]
Zhao, Y. [1 ]
Zhou, Y. [1 ]
Pan, B. [1 ]
Liu, T. [2 ]
Guo, W. [1 ]
机构：
[1] Fudan Univ, Zhongshan Hosp, Lab Med, Shanghai, Peoples R China
[2] Fudan Univ, Zhongshan Hosp, Med Oncol, Shanghai, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
基金：
中国国家自然科学基金;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
626P
引用
收藏
页码：237 / 237
页数：1
相关论文
共 50 条
  • [1] Clonal Hematopoiesis Mutations in Plasma cfDNA RAS/BRAF Genotyping of Metastatic Colorectal Cancer
    Wang, B.
    Huang, F.
    Shen, M.
    Wu, S.
    Wang, H.
    Jiang, H.
    Yu, Y.
    Yu, Q.
    Yang, Y.
    Zhao, Y.
    Zhou, Y.
    Pan, B.
    Liu, T.
    Guo, W.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (06): : 1187 - 1187
  • [2] Clonal hematopoiesis mutations in plasma cfDNA RASIBRAF genotyping of metastatic colorectal cancer.
    Wang, Beili
    Huang, Fei
    Shen, Minna
    Wu, Shengchao
    Yu, Qian
    Jiang, Huiqin
    Yu, Yiyi
    Yang, Yihui
    Zhao, Ying
    Zhou, Yiwen
    Pan, Baishen
    Liu, Tianshu
    Guo, Wei
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [3] Concomitant BRAF and RAS Mutations in Metastatic Colorectal Cancer
    Srivastav, Jigisha
    Lima, Caio Rocha
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S309 - S310
  • [4] Chemotherapy-associated clonal hematopoiesis mutations should be taken seriously in plasma cell-free DNA KRAS/NRAS/BRAF genotyping for metastatic colorectal cancer
    Huang, Fei
    Yang, Yihui
    Chen, Xinning
    Jiang, Huiqin
    Wang, Hao
    Shen, Minna
    Yu, Yiyi
    Liu, Tianshu
    Pan, Baishen
    Wang, Beili
    Guo, Wei
    CLINICAL BIOCHEMISTRY, 2021, 92 : 46 - 53
  • [5] RAS and BRAF in metastatic colorectal cancer management
    Gong, Jun
    Cho, May
    Fakih, Marwan
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2016, 7 (05) : 687 - 704
  • [6] Prognostic effect of RAS/BRAF mutations in patients (pts) with metastatic colorectal cancer (mCRC)
    Abid, Haisam
    Szabo, Aniko
    Taylor, Bradley W.
    Shreenivas, Aditya V.
    Chakrabarti, Sakti
    Kamgar, Mandana
    Thomas, James P.
    George, Ben
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [7] Genotyping-RAS mutations analysis in colorectal cancer
    Aschie, M.
    Poinareanu, I.
    Cozaru, G. C.
    Mitroi, A. F.
    Branzan, C.
    Aschie, D.
    Baltatescu, G. I.
    Enciu, M.
    Nicolau, A. A.
    Chisoi, A.
    Cojocaru, O.
    VIRCHOWS ARCHIV, 2017, 471 : S198 - S198
  • [8] BRAF and RAS mutations as prognostic factors in metastatic colorectal cancer patients undergoing liver resection
    M Schirripa
    F Bergamo
    C Cremolini
    M Casagrande
    S Lonardi
    G Aprile
    D Yang
    F Marmorino
    G Pasquini
    E Sensi
    C Lupi
    G De Maglio
    N Borrelli
    S Pizzolitto
    G Fasola
    R Bertorelle
    M Rugge
    G Fontanini
    V Zagonel
    F Loupakis
    A Falcone
    British Journal of Cancer, 2015, 112 : 1921 - 1928
  • [9] Prevalence of RAS and BRAF mutations in metastatic colorectal cancer (mCRC) patients by tumor location.
    Bylsma, Lauren C.
    Gillezeau, Christina
    Garawin, Tamer
    Kelsh, Michael Anthony
    Fryzek, Jon
    Sangare, Laura
    Lowe, Kimberly
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [10] Prognostic effect of specific RAS/BRAF mutations in patients (pts) with metastatic colorectal cancer (mCRC).
    George, Ben
    Taylor, Bradley W.
    Lasowski, Matthew
    Ritch, Paul S.
    Shreenivas, Aditya Varnam
    Chakrabarti, Sakti
    Kamgar, Mandana
    Zimmermann, Michael T.
    Reddi, Honey, V
    Urrutia, Raul
    Thomas, James P.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345